Accredo
Privacy |  HIPAA |  Terms of use |  Medco |  Contact us
   
Patients Healthcare professionals Health plans & payor clients Manufacturers Careers About Accredo
 
 
 

Patients

Getting started with Accredo
Our services
Search drug therapies
Therapy management
Disposal of unused meds
Adagen® (pegademase bovine) - product information

Adagen® (pegademase bovine)

Overview | Product information | Accredo services | Contact team


Adagen is an enzyme replacement therapy indicated for adenosine deaminase (ADA) deficiency in patients with severe combined immunodeficiency disease (SCID) who are not suitable candidates for—or who have failed—bone marrow transplantation.

For more information, please download the full prescribing information.


Adagen is a registered trademark of Sigma-Tau Pharmaceuticals, Inc.

 
 
 

Quick links

Search Search drug therapies
Doctor Referral Doctor referral forms
Patient Authorization Patient authorization form
Contact Us Contact us